Cited by 296Nitric Oxide and Endothelin EffectsRedox biology and oxidative stressNeutrophil, Myeloperoxidase and Oxidative Mechanisms

AMPKα2 Deletion Causes Aberrant Expression and Activation of NAD(P)H Oxidase and Consequent Endothelial Dysfunction In Vivo: Role of 26S Proteasomes

Open access
Wang, Shuangxi, Zhang, Miao, Liang, Bin, Xu, Jian, Xie, Zhonglin, Liu, Chao, Viollet, Benoit, Yan, Daoguang +1 more·2010·Circulation Research

Abstract

RATIONALE: AMP-activated protein kinase (AMPK) is an energy sensor and ubiquitously expressed in vascular cells. Recent studies suggest that AMPK activation improves endothelial function by counteracting oxidative stress in endothelial cells. How AMPK suppresses oxidative stress remains to be established. OBJECTIVE: The aim of this study is to examine the effects of AMPK in regulating NAD(P)H oxidase, oxidative stress, and endothelial function. METHODS AND RESULTS: The markers of oxidative stress, NAD(P)H oxidase subunit expression (gp91(phox), p47(phox), p67(phox), NOX1 to -4), NAD(P)H oxidase-mediated superoxide production, 26S proteasome activity, IkappaBalpha degradation, and nuclear translocation of nuclear factor (NF)-kappaB (p50 and p65) were examined in cultured human umbilical vein endothelial cells and mouse aortas isolated from AMPKalpha2 deficient mice. Compared to the wild type, acetylcholine-induced endothelium-dependent relaxation was significantly impaired in parallel with increased production of oxidants in AMPKalpha2(-/-) mice. Further, pretreatment of aorta with either superoxide dismutase (SOD) or tempol or apocynin significantly improved acetylcholine-induced endothelium-dependent relaxation in AMPKalpha2(-/-) mice. Analysis of aortic endothelial cells from AMPKalpha2(-/-) mice and human umbilical vein endothelial cells expressing dominant negative AMPK or AMPKalpha2-specific siRNA revealed that loss of AMPK activity increased NAD(P)H oxidase subunit expression (gp91(phox), p47(phox), p67(phox), NOX1 and -4), NAD(P)H oxidase-mediated superoxide production, 26S proteasome activity, IkappaBalpha degradation, and nuclear translocation of NF-kappaB (p50 and p65), whereas AMPK activation by AICAR or overexpression of constitutively active AMPK had the opposite effect. Consistently, we found that genetic deletion of AMPKalpha2 in low-density lipoprotein receptor knockout (LDLr(-/-)) strain markedly increased 26S proteasome activity, IkappaB degradation, NF-kappaB transactivation, NAD(P)H oxidase subunit overexpression, oxidative stress, and endothelial dysfunction, all of which were largely suppressed by chronic administration of MG132, a potent cell permeable proteasome inhibitor. CONCLUSIONS: We conclude that AMPKalpha2 functions as a physiological suppressor of NAD(P)H oxidase and ROS production in endothelial cells. In this way, AMPK maintains the nonatherogenic and noninflammatory phenotype of endothelial cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.109.212530

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AMPK negatively regulates NOX by reducing its phosphorylation and preventing P47phox's translocation to membrane.

    “Additional evidence supporting AMPK protection against oxidative stress is that AMPK negatively regulates NOX by reducing its phosphorylation and preventing P47phox’s translocation to membrane [70,151].”

    From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [70]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, S., Zhang, M., Liang, B., Xu, J., Xie, Z., Liu, C., Viollet, B., Yan, D., & Zou, M.-H.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • From the Section of Endocrinology and Diabetes (S.W., M.Z., B.L., J.X., Z.X., C.L., D.Y., M.-H.Z.), Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City; Institut Cochin (B.V.), Centre National de la Recherche Scientifique (Unité Mixte de Recherche 8104), University Paris Descartes, Paris, France; Institut National de la Santé et de la Recherche Médicale (B.V.), U1016, Paris, France; and College of Life Science (B.V.), Jinan University, Guangzhou, China.
Venue
Circulation Research
Published
2010-04-02
Volume
106
Issue
6
Pages
1117-1128
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W1964266642
Cited by
296
References
41
Citations by year
2026: 4 · 2025: 3 · 2024: 9 · 2023: 12 · 2022: 8 · 2021: 13 · 2020: 24 · 2019: 18 · 2018: 26 · 2017: 28 · 2016: 34 · 2015: 27 · 2014: 26 · 2013: 20 · 2012: 20
FWCI
13.63
Type
journal article
Language
en
Open access
Locations
  • Circulation Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL105157, HL 079584, R01HL079584, HL-080499, HL096032, HL074399, R01HL074399, R01HL080499, HL-089920, R01HL110488, R01HL089920, R01HL096032)
Topics
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Keywords
AMPKα2, AMPK, NADPH oxidase, endothelial dysfunction, oxidative stress, NF-κB signaling, 26S proteasome, superoxide production, NOX1, NOX4, LDL receptor, atherosclerosis, acetylcholine-induced relaxation, AICAR, tempol, apocynin, superoxide dismutase, p47phox, p67phox, gp91phox, LDL oxidation
MeSH terms
NF-KappaB Inhibitor alpha, Acetophenones, Acetylcholine, Aminoimidazole Carboxamide, Animals, Antioxidants, Cells, Cultured, Cyclic N-Oxides, Dose-Response Relationship, Drug, Endothelium, Vascular, Enzyme Activation, Enzyme Inhibitors, Humans, Interferon-gamma, Interleukin-2, Isoenzymes, Leupeptins, Male, Mice, Inbred C57BL, Nitroprusside, Receptors, LDL, Ribonucleotides, Spin Labels, Superoxides, Superoxide Dismutase, Transfection, Vasodilation, Vasodilator Agents, Gene Expression Regulation, Enzymologic, NF-kappa B, Gene Deletion, Mice, Knockout, Oxidative Stress, Inflammation Mediators, NADPH Oxidases, I-kappa B Proteins, RNA Interference, Endothelial Cells, Proteasome Endopeptidase Complex, Mice, AMP-Activated Protein Kinases, Proteasome Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review